<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Yu Y</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Deep vein catheterization is common in patients with advanced cancer, but safety and cost comparisons between catheter types are limited.&lt;h4>Purpose&lt;/h4>To evaluate the safety and economic impact of a modified medium-length catheter versus a standard peripherally inserted central catheter (PICC) line in patients with advanced cancer.&lt;h4>Methods&lt;/h4>A prospective cohort study was conducted involving 160 patients with advanced cancer receiving palliative care between January 2022 and April 2024. Patients were randomized to a study group (modified medium-length catheter) or control group (PICC line). Venous complications, satisfaction, and costs were compared.&lt;h4>Results&lt;/h4>The study group had lower rates of venous thrombosis, bleeding, and catheter infection. Patient sati</pubmed_abstract><journal>Journal of nursing care quality</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12919650</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Safety and Cost Evaluation of Modified Medium-Length Catheters in Patients With Advanced Cancer: A Randomized Controlled Trial.</pubmed_title><pmcid>PMC12919650</pmcid><pubmed_authors>Yan J</pubmed_authors><pubmed_authors>Zhou Q</pubmed_authors><pubmed_authors>Wang B</pubmed_authors><pubmed_authors>Ye G</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Yu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Safety and Cost Evaluation of Modified Medium-Length Catheters in Patients With Advanced Cancer: A Randomized Controlled Trial.</name><description>&lt;h4>Background&lt;/h4>Deep vein catheterization is common in patients with advanced cancer, but safety and cost comparisons between catheter types are limited.&lt;h4>Purpose&lt;/h4>To evaluate the safety and economic impact of a modified medium-length catheter versus a standard peripherally inserted central catheter (PICC) line in patients with advanced cancer.&lt;h4>Methods&lt;/h4>A prospective cohort study was conducted involving 160 patients with advanced cancer receiving palliative care between January 2022 and April 2024. Patients were randomized to a study group (modified medium-length catheter) or control group (PICC line). Venous complications, satisfaction, and costs were compared.&lt;h4>Results&lt;/h4>The study group had lower rates of venous thrombosis, bleeding, and catheter infection. Patient sati</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-07-16T09:56:53.442Z</modification><creation>2026-07-09T10:49:38.681Z</creation></dates><accession>S-EPMC12919650</accession><cross_references><pubmed>40839805</pubmed><doi>10.1097/NCQ.0000000000000905</doi></cross_references></HashMap>